{"id":"W2741974392","doi":"10.1016/j.rmed.2017.07.062","title":"Therapeutic targets in idiopathic pulmonary fibrosis","year":2017,"lang":"en","type":"review","venue":"Respiratory Medicine","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Boehringer Ingelheim; Gilead Sciences; Canadian Pulmonary Fibrosis Foundation; GlaxoSmithKline","keywords":"Nintedanib; Medicine; Pirfenidone; Idiopathic pulmonary fibrosis; Clinical trial; Interstitial lung disease; Disease; Pulmonary fibrosis; Pathogenesis; Intensive care medicine; Lung; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072002,0.0009763927,0.002307635,0.00241724,0.0003032211,0.001519288,0.000863125,0.001318844,0.005072603],"category_scores_gemma":[0.001057551,0.0003823872,0.0007436476,0.001971891,0.0004407409,0.001331326,0.001013173,0.002414998,0.001584089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004411881,"about_ca_system_score_gemma":0.001062399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006731781,"about_ca_topic_score_gemma":0.00200666,"domain_scores_codex":[0.9997597,0.00005007111,0.00005019987,0.00003084113,0.00007801245,0.00003109594],"domain_scores_gemma":[0.9995957,0.0002261412,0.00007486538,0.00001015839,0.00006405982,0.00002904373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001404419,0.00009436683,0.0001571678,0.03887958,0.0002111598,0.000264522,0.00006564911,0.0005042129,0.001359044,0.003653883,0.03272964,0.9219403],"study_design_scores_gemma":[0.0001041943,0.0001569043,0.0007558161,0.01459801,0.0005569715,0.001186182,0.00008201975,0.0002046806,0.0003534895,0.002809112,0.9791629,0.00002969318],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004826286,0.9990118,0.00006213128,0.0001553812,0.0001482779,0.000004796586,0.00001516197,0.000004208275,0.0005500134],"genre_scores_gemma":[0.0005284748,0.9986011,0.0001261988,0.0002552214,0.0001540221,0.000006814963,0.00002381952,9.771974e-7,0.0003034462],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005072603,"threshold_uncertainty_score":0.0169695,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1395791827068743,"score_gpt":0.4058700869435454,"score_spread":0.266290904236671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}